global Plasmid DNA Manufacturing Market Growth Accelerated by Increasing Demand for Novel Therapies

Lucy Kart

global Plasmid DNA Manufacturing Market Growth Accelerated by Increasing Demand for Novel Therapies

Plasmid DNA is genetic material used in manufacturing biopharmaceutical products and cell and gene therapies. It is advantageous for developing novel therapies due to its ability to manipulate gene expression and protein function in living cells.

The global Plasmid DNA Manufacturing Market is estimated to be valued at US$ 901.2 Bn in 2023 and is expected to exhibit a CAGR of 4.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

The increasing demand for cell and gene therapies has accelerated the growth of the plasmid DNA manufacturing market significantly. Cell and gene therapies are novel treatment options that replace, manipulate or supplement DNA/RNA to cure diseases. Plasmid DNA serves as an important component in the manufacturing of various cell and gene therapy products. With growing success of approved gene and cell therapy products, the demand for plasmid DNA from biopharmaceutical companies is expected to surge over the forecast period. This will propel the plasmid DNA manufacturing market growth.

Segment Analysis

The global Plasmid DNA Manufacturing Market is segmented on the basis of product, application, and end user. The product segment is further classified into DNA and RNA plasmids. Among them, the DNA plasmids sub-segment dominates the market owing to extensive research and therapeutic applications of DNA plasmids in gene therapy and vaccine production.

Key Takeaways

The global Plasmid DNA Manufacturing Market is expected to witness high growth over the forecast period of 2023 to 2030. Global Plasmid DNA Manufacturing Market Size is estimated to be valued at US$ 901.2 Bn in 2023 and is expected to exhibit a CAGR of 4.8% over the forecast period 2023 to 2030.

Regional analysis shows that North America region holds the largest share in the Plasmid DNA Manufacturing market currently due to increasing research investments by government and private players. The Asia Pacific region is expected to grow at the fastest pace during the forecast period due to improving healthcare infrastructure and increasing awareness about gene therapy applications.

Key players related content comprises

Key players operating in the Plasmid DNA Manufacturing market are Cobra Biologics and Pharmaceutical Services (Charles River Laboratories), VGXI, Inc., Aldevron (Danaher), Kaneka Corporation, Nature Technology, PlasmidFactory GmbH & Co. KG, Cell and Gene Therapy Catapult, LakePharma, Inc., MeiraGTx Limited, Eurofins Genomics, Vigene Biosciences, Luminous BioSciences (LBS), LLC, GenScript, GENEWIZ, Creative Biogene, Akron Biotech, Biomay, JAFRAL Ltd., WuXi Biologics, GeneImmune Biotechnology Corp., Lonza, Greenpak Biotech Ltd., Luina Bio (AcuraBio), Ajinomoto Bio-Pharma, Synbio Technologies, Genopis Inc., Altogen Biosystems, Puresyn, Inc., Cepham Life Sciences, Catalent, Inc., Biomiga, Waisman Biomanufacturing.

Get More Insights on this Topic- https://www.rapidwebwire.com/plasmid-dna-manufacturing-market-size-share-and-demand/

Lucy Kart

Plasmid DNA Manufacturing Market Expected To Reach US$735.67 Million By 2023

Ashish Thapa 2023-10-12

The development of novel gene editing technologies, such as CRISPR-Cas9, has further boosted the demand for plasmid DNA manufacturing. These advancements have paved the way for more precise and efficient gene therapies, driving the growth of the plasmid DNA manufacturing market. The global Plasmid DNA Manufacturing Market Growth is estimated to be valued at US$735. Segment Analysis: The plasmid DNA manufacturing market can be segmented based on end user and application. From a regional perspective, North America is the fastest-growing and dominating region in the plasmid DNA manufacturing market.

The Plasmid DNA Manufacturing Market Will Grow At A Highest Pace Owing To Increasing Demand For Gene And Cell Therapy

Mia Yates 2024-02-09

The Plasmid DNA Manufacturing Market involves the production, purification and manipulation of Plasmid DNA, which is circular DNA present in bacteria and certain other organisms. Impact of COVID-19 on Plasmid DNA Manufacturing Market The COVID-19 pandemic has significantly impacted the growth of the plasmid DNA manufacturing market. Pharmaceutical companies are developing COVID-19 vaccines using plasmid DNA technology which requires large-scale plasmid DNA production for clinical trials and commercialization purposes. Geographical Regions with Highest Plasmid DNA Manufacturing Market Value North America dominates the plasmid DNA manufacturing market in terms of value, accounting for over 35% share. Fastest Growing Regional Market for Plasmid DNA Manufacturing The Asia Pacific region is projected to be the fastest growing market for plasmid DNA manufacturing during 2024-2030.

mRNA Manufacturing is Fastest Growing Segment Fueling the Growth of Plasmid DNA Manufacturing Market

naufan003 2023-12-20

The Plasmid DNA manufacturing market is estimated to be valued at US$ 901. Additionally, advancement in DNA delivery systems, reducing manufacturing costs and rising R&D investments are some other factors expected to drive the plasmid DNA manufacturing market over the forecast period. Segment Analysis The global Plasmid DNA Manufacturing market is segmented on the basis of vector type, application, end user and region. By vector type, the market is segmented into Bacterial Plasmid DNA and Mammalian Plasmid DNA, of which bacterial plasmid DNA dominates the market and accounts for over 60% share. Regional analysis: North America accounts for the largest share in the global Plasmid DNA Manufacturing market, followed by Europe.

Plasmid DNA Manufacturing Market Is Estimated To Witness High Growth Owing To Increasing Drug Approvals For Gene Therapies

Sumedha 2023-11-07

The plasmid DNA manufacturing market is estimated to be valued at US$ 901. The demand for plasmid DNA is increasing as more number of gene therapy clinical trials and approvals are taking place. However, high cost associated with plasmid DNA production acts as a major challenge for market growth. SWOT Analysis Strength: Plasmid DNA manufacturing is gaining momentum due to the growing cell and gene therapy market. Key Takeaways The global Plasmid DNA Manufacturing market is expected to witness high growth, exhibiting a CAGR of 22.

Plasmid DNA Contract Manufacturing Market Demand Analysis, Statistics, Industry Trends And Investment Opportunities To 2028

Anisha Rathore 2023-03-17

The major players in the plasmid dna contract manufacturing market include Charles River Laboratories, VGXI Inc. Get more information on "Global Plasmid DNA Contract Manufacturing Market Research Report" by requesting FREE Sample Copy at https://www. com/contact/plasmid-dna-contract-manufacturing-market/download-sampleMarket DynamicsThe growing demand for gene therapy increases the need for plasmid DNA, which is driving the market for plasmid DNA contract manufacturing. Additionally, these tools also give an inclusive assessment of each segment in the global market of plasmid dna contract manufacturing. The growth and trends of plasmid dna contract manufacturing industry provide a holistic approach to this study.

Viral Vector & Plasmid DNA Manufacturing Market 2022 Size, Share & Forecast Report to 2028

Hanisha Sahu 2022-07-04

The latest Viral Vector & Plasmid DNA Manufacturing Market Research Report published by Value Market Research gives in-depth analysis to show industry trends in the upcoming years. The broad viral vector & plasmid DNA manufacturing market has been sub-grouped into product type, application and end-user. Request a FREE Sample Copy of Viral Vector & Plasmid DNA Manufacturing Market Report with Full TOC At: https://www. The key players in the viral vector & plasmid DNA manufacturing market include Cobra Biologics, FinVector Vision Therapies, FUJIFILM Diosynth Biotechnologies U. Purchase complete Global Viral Vector & Plasmid DNA Manufacturing Market Research Report At: https://www.

WHO TO FOLLOW

MORE FROM AUTHOR

Open source CRM software: Short Summary

Lucy Kart 2024-03-26

Next Generation Probiotics: Rising Significance of Health and Wellness

Lucy Kart 2024-03-22

Shavers - An Essential Grooming Tool

Lucy Kart 2024-03-22

The Rapid Rise of Europe E-bikes

Lucy Kart 2024-03-20

Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.

Press enter to search

Transforming Healthcare: Plasmid DNA Manufacturing Market Impact On Gene Therapies

sachin sadgir 2023-08-09

The Plasmid DNA Manufacturing Market is revolutionizing the field of healthcare through its profound impact on gene therapies. The Plasmid DNA Manufacturing Market has overcome numerous challenges to pave the way for effective gene therapies. The future of gene therapies powered by the Plasmid DNA Manufacturing Market is brimming with potential. As the Plasmid DNA Manufacturing Market grows, efforts to balance the cost of production and treatment affordability will be critical. The Plasmid DNA Manufacturing Market's impact on gene therapies is reshaping the landscape of healthcare.

Viral Vector & Plasmid DNA Manufacturing Market Size to reach $2.3 Billion and Registering a CAGR of 23.3% by 2027

Devanand Patil 2021-11-03

Transparency Market Research (TMR) has published a new report titled, ‘Viral Vector & Plasmid DNA Manufacturing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027.’ According to the report, the global viral vector & plasmid DNA manufacturing market was valued at US$ 0.4 Bn in 2018 and is projected to expand at a CAGR of 23.3% from 2019 to 2027.

Viral vectors are generally utilized as vectors for gene therapy.There are various types of vectors, such as lentivirus, adenovirus, adeno-associated virus (AAV), and others, which include herpes simplex virus and chimeric viral vectors.

Plasmid DNA is used as raw material in the production of various viral vectors.Technological advancements, increase in awareness about viral vector-based treatments, and rise in demand for vector-based products for research are the major factors anticipated to drive the global viral vector & plasmid DNA manufacturing market during the forecast periodNorth America held major share of the global viral vector & plasmid DNA manufacturing market in 2018.

Availability of the U.S. FDA (Food and Drug Administration) approved gene therapy products and rich product pipeline are the factors expected to augment the viral vector & plasmid DNA manufacturing market in the region during the forecast period.The viral vector & plasmid DNA manufacturing market in Asia Pacific is likely to expand at a high CAGR of5%from 2019 to 2027, due to recent developments in regenerative medicines, rise in prevalence of chronic diseases, and increase in demand for gene therapies.

Additionally, demand for viral vector & plasmid DNA is increasing in emerging markets such as India and China.

Request COVID Analysis on Viral Vector & Plasmid DNA Manufacturing Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=30428Rise in Prevalence of Cancer, Genetic Diseases, and Infectious Diseases to Propel Global Viral Vector & Plasmid DNA Manufacturing MarketRise in prevalence of cancer and genetic diseases is projected to augment the global viral vector & plasmid DNA manufacturing market during the forecast periodAccording to the Cancer Research UK, 17 millionnew cases of cancer were reported globally in 2018 and the four most common types of cancer were breast, lung, bowel, and prostate, which account for around 43% of all new casesAccording to the National Cancer Institute, cancer is among the leading causes of death across the world, and the number of new cases per year is anticipated to rise to 6 millionby 2030.Request Customization on Viral Vector & Plasmid DNA Manufacturing Market Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR_id=30428Plasmid DNA Segment Dominated Global Viral Vector & Plasmid DNA Manufacturing MarketIn terms of type, the global viral vector & plasmid DNA manufacturing market can be classified into lentivirus, adenovirus, adeno-associated virus (AAV), plasmid DNA, and othersThe plasmid DNA segment dominated the global viral vector & plasmid DNA manufacturing market in 2018and the trend is expected to continue during the forecast periodIncrease in use of plasmid DNA as raw material in the manufacture of viral vectors is likely to drive the segment during the forecast periodCancer to be Promising Segment of Global Viral Vector & Plasmid DNA Manufacturing MarketBased on disease, the global viral vector & plasmid DNA manufacturing market has been categorized into genetic disorders, cancer, infectious diseases, and othersThe cancer segment dominated the global viral vector & plasmid DNA manufacturing market in 2018and the trend is projected to continue during the forecast period owing to large number of ongoing clinical trials and availability of approved viral vector-based cancer drugsBiotech Companies to be Lucrative Segment of Global Viral Vector & Plasmid DNA Manufacturing MarketIn terms of end-user, the global viral vector & plasmid DNA manufacturing market has been categorized into biotech companies and research institutesThe biotech companies segment held major share of the global viral vector & plasmid DNA manufacturing market in 2018Increase in number of viral vector-based cancer drugs being manufactured by multinational players and several clinical trials underway for the treatment of various cancers are anticipated to propel the segment during the forecast periodBuy Viral Vector & Plasmid DNA Manufacturing Market Report – https://www.transparencymarketresearch.com/checkout.php?rep_id=30428=SNorth America to Dominate Global Market; Asia Pacific to Offer Significant Incremental OpportunityIn terms of region, the global viral vector & plasmid DNA manufacturing market has been segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & AfricaNorth America is projected to account for major share of the global viral vector & plasmid DNA manufacturing market during the forecast period, owing to high acceptance of viral vector-based gene therapies for the treatment of rare diseases and availability of FDA-approved gene therapiesThe viral vector & plasmid DNA manufacturing market in Asia Pacific is anticipated to grow at a rapid pace in the next few years.

Viral Vectors And Plasmid DNA Market Key Drivers, Trends, Size And Outlook 2023-2032

Bhuvan 2023-01-11

The Viral Vectors And Plasmid DNA Global Market Report 2023 evaluates viral vectors and plasmid DNA market size, growth rate, drivers, trends, and major companies. id=3245&type=smpThe global viral vectors & plasmid dna market grew from $0. The viral vectors & plasmid dna market is expected to grow from $1. The viral vectors and plasmid DNA market segments in the report are:1) By Product: Plasmid DNA, Viral Vectors2) By Application: Gene And Cancer Therapies, Viral Infections, Immunotherapy, Formulation Development, Other Applications3) By Disease: Infectious Diseases, Genetic Disorders, Cancer, Other Diseases4) By End User: Research Institutes, Biopharmaceutical And Pharmaceutical CompaniesGet More Information On The Viral Vectors And Plasmid DNA Market Report:https://www. Competitive Landscape And Company ProfilesKey Mergers And AcquisitionsFuture Outlook and Potential AnalysisTop 5 Major Key Players Are:FUJIFILM Diosynth BiotechnologiesFinVector Vision TherapiesLonzaCobra Biologics and Pharmaceutical ServicesBrammer BioList Of Tables:Table 1: Global Historic Market Growth, 2017-2022, $ BillionTable 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ BillionTable 3: Global Viral Vectors & Plasmid DNA Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ BillionTable 4: Global Viral Vectors & Plasmid DNA Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ BillionTable 5: Global Viral Vectors & Plasmid DNA Market, Segmentation By Disease, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion….

CD Genomics Perspective: DNA-Based Technologies for Detection of Foodborne Microorganisms

Kiko Garcia 2021-11-29

Contamination can occur by air, water, soil contamination and at different points during the growing, harvesting, processing, and preparation of food crops. An imperative concern in the scientific community is the fast detection and diagnosis of microorganisms. Electrophoretic isolation investigates the resultant DNA fragments. Proof of evolving DNA sequences is the presence, lack, or changes in the mass of the resultant DNA fragments. These assist in the development of novel approaches for microbial pathogen detection and drug design and drug development.

Viral Vectors and Plasmid DNA Manufacturing Market Research Report with Outlook, Strategies, Challenges, Geography Trends

nilesh 2022-02-24

According to MRFR analysis, the global viral vector and plasmid DNA manufacturing market is expected to register a CAGR of ~16. Severalkey players are dominating the global viral vector and plasmid DNA manufacturing market, contributing to a significant revenue share. Key PlayersSome of the key players in the global Viral Vector and Plasmid DNA Manufacturing market are Cognate BioServices, Inc. Regional AnalysisBased on region, North America is expected to dominate the global viral vector and plasmid DNA manufacturing market in 2020. Europe is expected to hold the second-largest position in the global viral vector and plasmid DNA manufacturing market in 2021.

Advancements Of Plasmid DNA Manufacturing In Disease Management

Pooja salve 2023-06-26

Another area where plasmid DNA manufacturing shows great potential is in the development of DNA vaccines. Traditional vaccines often use weakened or inactivated forms of pathogens, whereas DNA vaccines deliver the genetic instructions for producing a specific antigen directly into cells. This approach stimulates an immune response, leading to the production of antibodies and activation of T cells. Beyond gene therapy and DNA vaccines, Plasmid DNA Manufacturing holds great promise in advancing disease management strategies. Furthermore, plasmid DNA technology can facilitate the production of RNA-based therapeutics, such as mRNA vaccines and RNA interference (RNAi) therapies.

The Rapid Adoption Of Connected Devices Is Projected To Boost The Growth Of Iot In Manufacturing Market

Lucy Kart 2023-11-24

The global IoT in Manufacturing Market is estimated to be valued at US$ 235. Porter’s Analysis Threat of new entrants: The threat of new entrants is moderate. Bargaining power of buyers: The bargaining power of buyers is high due to availability of various IoT solutions in the market. Rapid advancements in connectivity, automation, and analytics are driving adoption of IoT across industries. Regionally, North America dominated the IoT in Manufacturing market in 2023 with a share of over 30%, owing to strong industrial automation trends in the US.

The use of Viral Vector and Plasmid DNA Testing Services is gaining a great deal of popularity worldwide

Vivek Vishwakarma 2021-10-08

Viral Vector and Plasmid DNA Testing Services is a complex technology that aids in the precise identification of viral and fungal infections.

Various companies provide this service in various regions.

The majority of these DNA laboratories utilise various methodologies to test the test results.

Polymerase chain reaction (PCR) is the most used method for evaluating viral vector and plasmid DNA (PCR).

It entails boiling and electrophoresis of diverse material repeatedly to produce lengthy strings of identical DNA strands.

The presence of viral or fungal infections in humans is then detected using this DNA sequence.Apart from Viral Vector and Plasmid DNA Testing Services, there are other additional DNA testing alternatives available, including polymerase chain reactions (PCRs), direct primers, DNA cloning, and many others.

Viral Vectors and Plasmid DNA Manufacturing Market Size, Industry Growth and Top Leaders

nilesh 2021-11-29

Severalkey players are dominating the global viral vector and plasmid DNA manufacturing market, contributing to a significant revenue share. According to MRFR analysis, the global viral vector and plasmid DNA manufacturing market is expected to register a CAGR of ~16. SegmentationThe global viral vector and plasmid DNA manufacturing market has been segmented intovector type, workflow, disease type, application, and end user. Regional AnalysisBased on region, North America is expected to dominate the global viral vector and plasmid DNA manufacturing market in 2020. Europe is expected to hold the second-largest position in the global viral vector and plasmid DNA manufacturing market in 2021.

Viral Vector & Plasmid DNA Manufacturing Market 2022 Size, Share & Forecast Report

Deniyal Berich 2023-07-14

Wide Range of Applications in Medical Sector of DNA Nanotechnology Market

Sneha 2024-03-21

The Global DNA Nanotechnology Market Demand is estimated to be valued at US$ 4. Key TakeawaysKey players operating in the Global DNA Nanotechnology market are NuProbe, GATTAQUANT GMBH, Genisphere LLC, INOVIO Pharmaceuticals. The growing healthcare industry and increasing adoption of nanotechnology present strong opportunities in the DNA nanotechnology market. Geographically, North America dominates the global DNA nanotechnology market. Get more insights on DNA Nanotechnology Market

Plasmid DNA Manufacturing Market Anticipated Growing at a CAGR of 21.7% By 2030

Precedence Research 2022-02-23

The global Plasmid DNA Manufacturing Market size is predicted to account USD 2. A recent study by Precedence Research on the plasmid DNA manufacturing market offers a forecast for 2022 and 2030. The study analyzes crucial trends that are currently determining the growth of the plasmid DNA manufacturing market. The study also provides the dynamics that are responsible for influencing the future status of the plasmid DNA manufacturing market over the forecast period. Contact Us: Precedence Research Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, CanadaCall: +1 9197 992 333Email: sales@precedenceresearch.

Viral vector and plasmid dna manufacturing market Size, Cost Structure, Growth Analysis and Forecasts to 2027

kiran gaikwad 2020-05-28

Industry Overview of the Report 2026:The market intelligence report on the Global Viral Vector and Plasmid DNA Manufacturing‎ Market offers the readers a 360° market overview with definitions, market segments, applications, raw material used, product details, cost structures, production processes, and other essential data.

The study evaluates the global market landscape, with an in-depth analysis of product pricing, production and consumption volume, cost, value, production capacity, supply and demand dynamics, annual market growth rate, and market estimation till 2026.This report covers the recent COVID-19 incidence and its impact on Viral Vector and Plasmid DNA Manufacturing Market.

The pandemic has widely affected the economic scenario.

This study assesses the current landscape of the ever-evolving business sector and the present and future effects of COVID-19 on the market.To get a sample of this report, with 30 minutes free consultation, visit @ https://www.reportsanddata.com/sample-enquiry-form/1938 The Global Viral Vector and Plasmid DNA Manufacturing‎ Market Can Be Segmented By:Leading Players: FUJIFILM Diosynth Biotechnologies, Kaneka Eurogentec S.A, Fin vector, Spark therapeutics, Cobra biologics, Cell and gene therapy catapult, Renova therapeutics, Shenzhen SiBiono GeneTech Co., Ltd, Thermo Fisher Scientific, Inc, 4D Molecular Therapeutics are the major players in the Viral vector and plasmid DNA manufacturing market.Segmentation: By Product (Revenue, USD Million; 2016-2026)Plasmid DNAViral VectorsNon-viral VectorsBy Workflow (Revenue, USD Million, 2014 - 2026)Upstream ProcessingVector Amplification & ExpansionVector Recovery/HarvestingDownstream ProcessingPurificationFill-finishBy Disease (Revenue, USD Million; 2016-2026)CancerInherited DisordersViral InfectionsOthersBy Application (Revenue, USD Million, 2016-2026)Antisense, RNAi, & Molecular TherapyVaccinologyBy Sales channel (Revenue, USD Million; 2016-2026)Channel salesDirect SalesBy End user: (Revenue, USD Million; 2016-2026)Pharmaceutical and Biopharmaceutical CompaniesResearch InstitutesRegional Viral Vector and Plasmid DNA Manufacturing Market (Regional Output, Demand & Forecast by Countries):- North America (United States, Canada, Mexico)South America (Brazil, Argentina, Ecuador, Chile)Asia Pacific (China, Japan, India, Korea)Europe (Germany, UK, France, Italy)Middle East Africa (Egypt, Turkey, Saudi Arabia, Iran) and More.

The study also provides a meticulous evaluation of the key threats faced by the pioneers of the market, which allows the participants to comprehend the challenges they may encounter in the future as part of the global market in the forecast duration.The Market Report Contains The Following Chapters:Chapter 1: This report on the Global Viral Vector and Plasmid DNA Manufacturing‎ Market brings in one place all the vital information pertaining to the sector.Chapter 2: The report comprises of a detailed analysis of players that account for a significant portion of the global market share in the Viral Vector and Plasmid DNA Manufacturing‎ industry, highlighting the company’s latest technological advancement in the market, and the product profile currently available in the market, as well as the regions where they predominantly operate.Chapter 3: It helps understand the major product segments and the future of the Global Viral Vector and Plasmid DNA Manufacturing‎ Market.

It gives strategic measures in key business segments based on market estimations.Chapter 4: The report also provides an eight-year forecast survey predicting the growth of the market in the forecast duration.The Viral Vector and Plasmid DNA Manufacturing‎ industry research report outlines aspects like production, demand and supply, sales, and the contemporary market scenario exhaustively.

Growing applications of advanced biologics projected to boost the growth of Recombinant DNA Technology Market

Purvaja 2023-12-12

This new recombinant DNA is then inserted into host cells that are cultured in bioreactors and allowed to express the introduced genetic material. The global recombinant Dna Technology Market is estimated to be valued at US$ 156. Key TakeawaysThe global Recombinant Dna Technology Market Share is expected to witness high growth, exhibiting CAGR of 7. The recombinant dna technology market in Asia Pacific is anticipated to witness fastest growth during the forecast period attributed to rising geriatric population, increasing healthcare spending, and growing awareness. Key players operating in the recombinant dna technology market include Pfizer, Sanofi, New England Biolabs, GlaxoSmithKline plc, GenScript, Thermo Fisher Scientific, Inc.